Cadinha & Co. LLC Sells 1,525 Shares of The Procter & Gamble Company (NYSE:PG)

Cadinha & Co. LLC lessened its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 21.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,570 shares of the company’s stock after selling 1,525 shares during the period. Cadinha & Co. LLC’s holdings in Procter & Gamble were worth $965,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble in the second quarter worth about $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at approximately $29,000. Transcendent Capital Group LLC acquired a new stake in Procter & Gamble in the 4th quarter valued at $31,000. Ruedi Wealth Management Inc. grew its stake in Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the period. Finally, POM Investment Strategies LLC acquired a new stake in Procter & Gamble during the 2nd quarter worth $34,000. Institutional investors own 65.77% of the company’s stock.

Insiders Place Their Bets

In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the transaction, the chief executive officer now directly owns 269,172 shares in the company, valued at approximately $46,203,373.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 383,194 shares of company stock worth $65,140,718 in the last ninety days. 0.17% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

PG has been the topic of a number of recent research reports. Piper Sandler began coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Dbs Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Citigroup increased their price objective on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Finally, BNP Paribas began coverage on Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 target price on the stock. Ten equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $175.05.

Read Our Latest Analysis on PG

Procter & Gamble Price Performance

Shares of Procter & Gamble stock traded down $0.38 during trading hours on Thursday, reaching $168.89. The company’s stock had a trading volume of 760,257 shares, compared to its average volume of 6,653,722. The stock has a market cap of $398.60 billion, a P/E ratio of 27.66, a P/E/G ratio of 3.73 and a beta of 0.41. The Procter & Gamble Company has a one year low of $141.66 and a one year high of $177.94. The firm has a 50 day moving average price of $171.39 and a 200-day moving average price of $166.65. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. The business had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.37 earnings per share. On average, analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.39%. Procter & Gamble’s dividend payout ratio is currently 65.69%.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.